Cargando…
ALK Inhibitors-Induced M Phase Delay Contributes to the Suppression of Cell Proliferation
Anaplastic lymphoma kinase (ALK), a receptor-type tyrosine kinase, is involved in the pathogenesis of several cancers. ALK has been targeted with small molecule inhibitors for the treatment of different cancers, but absolute success remains elusive. In the present study, the effects of ALK inhibitor...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226408/ https://www.ncbi.nlm.nih.gov/pubmed/32344689 http://dx.doi.org/10.3390/cancers12041054 |